國立高雄大學圖資館 |

Language: English

Back

Nanotechnology-COVID-19 interface

SpringerLink (Online service)

Nanotechnology-COVID-19 interface

Record Type:	Electronic resources : Monograph/item
Title/Author:	Nanotechnology-COVID-19 interfaceby Devasena T.
Author:	T., Devasena.
Published:	Singapore :Springer Singapore :2021.
Description:	viii, 142 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	COVID-19 (Disease)
Online resource:	https://doi.org/10.1007/978-981-33-6300-7
ISBN:	9789813363007$q(electronic bk.)

Nanotechnology-COVID-19 interface
T., Devasena.

Nanotechnology-COVID-19 interface[electronic resource] /by Devasena T. - Singapore :Springer Singapore :2021. - viii, 142 p. :ill., digital ;24 cm. - SpringerBriefs in applied sciences and technology. Nanotheranostics. - SpringerBriefs in applied sciences and technology.Nanotheranostics..

1. introduction to COVID-19 -- 2. STRUCTURE OF SARS COV2 -- 3. TROPISM OF SARS COV2 -- 4. NANOTECHNOLOGY-COVID 19 INTERFACE -- 5. NANOPARTICLES IN DIAGNOSIS OF COVID-19.

This book highlights the role of nanotechnology concepts in the management of COVID-19 pandemic. The book covers different aspects of the causative agent SARS CoV2 (Severe Acute Respiratory Syndrome Coronavirus-2) and the COVID-19 pandemic with a special emphasis on nanotechnology. It discusses the origin and history of SARS CoV2 and the outbreak of COVID-19 and highlights the geographical mutations in the SARS CoV2 virus genome, providing information about the structural features, antigenicity and the life cycle of SARS CoV2. The book provides an insight into nanotechnology-virology interface and explains how nanomaterials link the gap between the vital phases of SARS CoV2 life cycle and the four modalities of COVID-19 management viz sensing/diagnosis, therapy, prevention and self-protection. Further, the existing and promising diagnostic tools for detection of COVID-19 are discussed with an emphasis on nano PCR, nanoimmunosensors, biobarcode assay and point of care approach and also describe the nanoparticles involved in the CT imaging of lungs and SFHI (Spatial Frequency Hetrodyne Imaging) for diagnosis of SARS COV2 infection. The book concludes with details about translational medicine and explains the types of SARS CoV2 vaccines, stages of COVID-19 vaccine development and possible nanovaccines for COVID-19, followed by the description on biopharmaceutical companies involved in the production of SARS CoV2 vaccines.

ISBN: 9789813363007$q(electronic bk.)

Standard No.: 10.1007/978-981-33-6300-7doiSubjects--Topical Terms:

877725
COVID-19 (Disease)

LC Class. No.: RA644.C67 / T22 2021

Dewey Class. No.: 614.592414

Nanotechnology-COVID-19 interface
LDR:02690nmm a2200349 a 4500 001 600747
003 DE-He213
005 20210617094713.0
006 m d
007 cr nn 008maaau
008 211104s2021 si s 0 eng d
020 $a 9789813363007$q(electronic bk.)
020 $a 9789813362994$q(paper)
024 7 $a 10.1007/978-981-33-6300-7 $2 doi
035 $a 978-981-33-6300-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RA644.C67 $b T22 2021
072 7 $a PHVN $2 bicssc
072 7 $a SCI009000 $2 bisacsh
072 7 $a PHVN $2 thema
072 7 $a PHVD $2 thema
082 0 4 $a 614.592414 $2 23
090 $a RA644.C67 $b T111 2021
100 1 $a T., Devasena. $3 895416
245 1 0 $a Nanotechnology-COVID-19 interface $h [electronic resource] / $c by Devasena T.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a viii, 142 p. : $b ill., digital ; $c 24 cm.
490 1 $a SpringerBriefs in applied sciences and technology. Nanotheranostics
505 0 $a 1. introduction to COVID-19 -- 2. STRUCTURE OF SARS COV2 -- 3. TROPISM OF SARS COV2 -- 4. NANOTECHNOLOGY-COVID 19 INTERFACE -- 5. NANOPARTICLES IN DIAGNOSIS OF COVID-19.
520 $a This book highlights the role of nanotechnology concepts in the management of COVID-19 pandemic. The book covers different aspects of the causative agent SARS CoV2 (Severe Acute Respiratory Syndrome Coronavirus-2) and the COVID-19 pandemic with a special emphasis on nanotechnology. It discusses the origin and history of SARS CoV2 and the outbreak of COVID-19 and highlights the geographical mutations in the SARS CoV2 virus genome, providing information about the structural features, antigenicity and the life cycle of SARS CoV2. The book provides an insight into nanotechnology-virology interface and explains how nanomaterials link the gap between the vital phases of SARS CoV2 life cycle and the four modalities of COVID-19 management viz sensing/diagnosis, therapy, prevention and self-protection. Further, the existing and promising diagnostic tools for detection of COVID-19 are discussed with an emphasis on nano PCR, nanoimmunosensors, biobarcode assay and point of care approach and also describe the nanoparticles involved in the CT imaging of lungs and SFHI (Spatial Frequency Hetrodyne Imaging) for diagnosis of SARS COV2 infection. The book concludes with details about translational medicine and explains the types of SARS CoV2 vaccines, stages of COVID-19 vaccine development and possible nanovaccines for COVID-19, followed by the description on biopharmaceutical companies involved in the production of SARS CoV2 vaccines.
650 0 $a COVID-19 (Disease) $3 877725
650 0 $a COVID-19 Pandemic, 2020- $3 890299
650 0 $a Nanomedicine. $3 273406
650 1 4 $a Biological and Medical Physics, Biophysics. $3 759746
650 2 4 $a Nanotechnology and Microengineering. $3 348421
650 2 4 $a Chemistry/Food Science, general. $3 274166
650 2 4 $a Biotechnology. $3 188829
650 2 4 $a Biomaterials. $3 274415
650 2 4 $a Sociology, general. $3 557597
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a SpringerBriefs in applied sciences and technology. $p Nanotheranostics. $3 715838
856 4 0 $u https://doi.org/10.1007/978-981-33-6300-7
950 $a Physics and Astronomy (SpringerNature-11651)